Related Experiment Video
Updated: Sep 30, 2025
09:16
Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
Published on: June 18, 2020
7.0K
Mitochondrial DNA-dependent inflammation in kidney diseases
Shilu Luo1, Ming Yang1, Hao Zhao1
1Department of Nephrology, the second Xiangya Hospital, Central South University, Changsha, Hunan, China.
International Immunopharmacology
|March 13, 2022
Summary
Mitochondrial DNA (mtDNA) leakage into the cytoplasm triggers inflammation, contributing to kidney diseases like acute kidney injury (AKI) and chronic kidney disease (CKD). Understanding this mechanism offers new research directions for kidney disease.
Area of Science:
- Nephrology
- Molecular Biology
- Immunology
Background:
- Mitochondrial dysfunction and nonbacterial inflammation are key in acute kidney injury (AKI) and chronic kidney disease (CKD).
- The precise pathophysiology of kidney disease progression remains incompletely understood.
- Mitochondria contain their own DNA (mtDNA), essential for mitochondrial respiratory complex protein synthesis.
Purpose of the Study:
- To discuss the structure and function of mitochondrial DNA (mtDNA).
- To emphasize the inflammatory pathways activated by mtDNA leakage into the cytoplasm.
- To summarize the role of mtDNA in kidney diseases and suggest future research avenues.
Main Methods:
- Literature review and synthesis of existing research on mtDNA structure, function, and cellular localization.
- Analysis of inflammatory signaling pathways triggered by extracellular or cytoplasmic mtDNA.
- Review of studies investigating mtDNA's involvement in the pathogenesis of kidney diseases.
Main Results:
- Mitochondrial DNA (mtDNA) leakage into the cytoplasm can initiate inflammatory responses.
- This process is implicated in the development of various diseases, including kidney conditions.
- Specific inflammatory pathways activated by released mtDNA have been identified.
Conclusions:
- Mitochondrial DNA (mtDNA) is a significant factor in kidney disease pathogenesis through inflammatory activation.
- Further research into mtDNA's role can elucidate kidney disease mechanisms.
- Targeting mtDNA-mediated inflammation may offer therapeutic strategies for AKI and CKD.
Related Concept Videos
01:24Chronic Kidney Disease II: Clinical Manifestations
132
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
132
01:29Acute Kidney Injury II: Pathophysiology
136
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
136
01:21Myocarditis I: Introduction
52
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
52
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
249
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
249
01:30Inflammatory Bowel Disease II: Crohn's Disease
434
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
434
01:25Chronic Kidney Disease I: Introduction
94
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
94